Professional Profile
Innovative biotech and MedTech executive with a proven track record in scaling operations, R&D strategy, and corporate growth across Fortune 500 companies and early-stage startups. As Chief Strategy & Operations Officer at Armora Biosciences, I drive pipeline advancement and commercialization pathways, ensuring investor alignment and market positioning for dermatology-focused innovations.
My leadership spans multi-million-dollar capital strategies, portfolio transformation, and the development and execution of global clinical development strategy for multiple drug programs, from preclinical stages through commercial launch. I have set regulatory strategies, overseeing submissions for IND, CTA, NDA, and BLA filings, securing global trial approvals, and engaging with health authorities to accelerate product development and commercialization.
Key Expertise
Corporate Strategy & Expansion – Spearheading growth initiatives, investor engagement, and high-value capital negotiations.
Board & Governance Leadership – Strategic advisory roles with MIT Solve, Harvard NVC, Creatella Impact, ReachBack, PHE, venture accelerators, and private equity firms.
Biotech & MedTech Market Entry – Proven ability to scale R&D pipelines, drive commercialization, and optimize business execution.
Operational & Financial Oversight – Deep expertise in budgeting, resource allocation, and financial governance in venture-backed biotech.
Board & Advisory Roles
With extensive corporate governance, investment strategy, and advisory experience, I contribute to boards and strategic panels, driving innovation and decision-making at the intersection of biotech, MedTech, and private equity investment.
Board Member – Peer Health Exchange – Strengthening healthcare innovation and policy influence through governance oversight and strategic direction.
Innovation Advisory – MIT Solve, Harvard NVC – Guiding breakthrough ventures in biotech and MedTech, fostering emerging talent and market positioning.
Strategic Leadership – Creatella Impact & ReachBack – Supporting early-stage startups with mentorship, commercialization frameworks, and global expansion strategies.
R&D & Market Acceleration – Steering organizations through clinical development, commercialization milestones, and interdisciplinary collaborations.
Corporate Restructuring & Change Leadership – Driving operational transformation in biotech ventures, ensuring long-term sustainability and impact.
As a board member and advisor, I provide governance oversight, strategic direction, and innovation guidance across biotech and MedTech ventures. This includes my role at Blackmon Technologies, where I support startups in refining their market strategy, commercialization efforts, and operational execution.
Education & Executive Training
I bring top-tier business and innovation expertise, reinforced by advanced education from Harvard Business School and MIT Sloan, equipping me with a strategic foundation in leadership, governance, venture capital, and technology-driven transformation.
Harvard Business School – General Management Program (GMP), Private Equity & Venture Capital, Succeeding as Corporate Director
MIT Sloan School of Management – Advanced Certificate for Executives in Management, Innovation & Technology
Columbia Business School – Angel Investing, Mergers & Acquisitions
Project Management Institute – PMP® Certification
Nicolaus Copernicus University – MSc in Laboratory Sciences
